Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Ann Transl Med ; 8(18): 1143, 2020 Sep.
Article in English | MEDLINE | ID: mdl-33240992

ABSTRACT

BACKGROUND: This retrospective study evaluated the safety and efficacy of concurrent anti-tuberculosis (TB) and chemotherapy treatment in patients with advanced lung cancer and active TB. METHODS: We retrospectively analyzed patients who were first diagnosed with advanced lung cancer and received first-line chemotherapy in Guangzhou Chest Hospital from 2015 to 2017. Patients were categorized into two groups (2:1): lung cancer patients without active TB (Group A), and lung cancer patients with active TB (Group B). Primary endpoints included adverse events (AEs), objective response rate (ORR), time to treatment failure, and overall survival (OS). RESULTS: A total of 99 patients were eligible (Group A, n=66; Group B, n=33). Grade ≥3 treatment-related AEs, primarily hematologic toxicity, occurred in 39.4% and 51.5% of patients in Groups A and B, respectively. The hypohepatia in both groups was generally at grade 1 or 2, with similar incidences (26% and 27%, respectively). After two cycles of chemotherapy, the ORR was 42.4% and 33.3% in Group A and B, respectively (P=0.383). The median time to treatment failure (TTF) was 7.0 and 5.6 months for Groups A and B, respectively (P=0.175). The median OS was 17.0 and 14.0 months for Groups A and B, respectively (P=0.312). After 3 months of anti-TB treatment, all patients achieved sputum acid-fast bacilli (AFB) smear conversion and absorption on imaging, and the end of follow-up observed no recurrence. CONCLUSIONS: Concurrent anti-TB and chemotherapy treatment did not increase hematological toxicity or hypohepatia in lung cancer patients with pulmonary TB.

2.
Sci Rep ; 7(1): 14927, 2017 11 02.
Article in English | MEDLINE | ID: mdl-29097732

ABSTRACT

This paper presents the use of nanorods of different sizes, deposited from a chemical solution, as an antireflection layer in copper-zinc-tin selenide (CZTSe) solar cells. With the aid of the nanorods, the surface reflection of the CZTSe solar cells was reduced from 7.76% to 2.97%, and a cell efficiency of 14% was obtained as a result. Omni-directional anti-reflection was verified by the angle-dependent reflection measurements. The nanorod arrays also provided the CZTSe solar cells with a hydrophobic surface, allowing it to exhibit high resistance against humidity during weatherability tests. This shows that the surface passivation brought by the nanorod layer at the surface could effectively extend the lifetime of the CZTSe solar cells. The rate of efficiency decay of the CZTSe solar cells was reduced by 46.85% from that of the device without a nanorod array at the surface, indicating that this surface layer not only provided effective resistance against reflection at the device surface, but also served as a passivation layer and humidity-resistant surface-protection layer.

SELECTION OF CITATIONS
SEARCH DETAIL
...